Transforming growth factor-β1 induces matrix metalloproteinase-9 expression in human meningeal cells via ERK and Smad pathways

Biochemical and Biophysical Research Communications

Volumn 383, Issue 4, 2009, Pages 475-479

  Okamoto, Toshio ^a   Takahashi, Satoru ^a   Nakamura, Eiki ^a   Nagaya, Ken ^a   Hayashi, Tokitsugi ^a   Fujieda, Kenji ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Extracellular signal regulated kinase; Human meningeal cells; Matrix metalloproteinase 9; Posthemorrhagic hydrocephalus; Smad; Transforming growth factor 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COMPLEMENTARY DNA; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYDROCEPHALUS; MENINX; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELLS, CULTURED; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; HUMANS; MATRIX METALLOPROTEINASE 9; MENINGES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67349145349     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.038     Document Type: Article

References (27)

1. Volpe J.J. Intracranial hemorrhage. In: Volpe J.J. (Ed). Neurology of the Newborn (2001), Saunders, Philadelphia 428-493
2. Whitelaw A., Cherian S., and Pople I. Transforming growth factor-β1: a possible signal molecule for posthemorrhagic hydrocephalus?. Pediatr. Res. 46 (1999) 576-580
3. Whitelaw A., Cherian S., Thoresen M., and Pople I. Posthaemorrhagic ventricular dilatation: new mechanisms and new treatment. Acta Paediatr. Suppl. 444 (2004) 11-14
4. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
5. Okamoto T., Takahashi S., Nakamura E., Nagaya K., Hayashi T., Shirai M., and Fujieda K. Matrix metalloproteinases in infants with posthemorrhagic hydrocephalus. Early Hum. Dev. 84 (2008) 137-139
6. Dziembowska M., Danilkiewicz M., Wesolowska A., Zupanska A., Chouaib S., and Kaminska B. Cross-talk between Smad and p38 MAPK signaling in transforming growth factor β signal transduction in human glioblastoma cells. Biochem. Biophys. Res. Commun. 354 (2007) 1101-1106
7. Safina A., Vandette E., and Bakin A.V. ALK5 promotes tumor angiogenesis by upregulation matrix metalloproteinase-9 in tumor cells. Oncogene 26 (2007) 2407-2422
8. Sinpitaksakul S.N., Pimkhaokham A., Sanchavanakit N., and Pavasant P. TGF-β1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem. Biophys. Res. Commun. 371 (2008) 713-718
9. Tian Y.C., Chen Y.C., Chang C.T., Hung C.C., Wu M.S., Phillips A., and Yang C.W. Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp. Cell. Res. 313 (2007) 2367-2377
10. Ishiwata I., Ishiwata C., Iguchi M., Soma M., Sato Y., Sonobe M., Kiguchi K., Tachibana T., and Ishikawa H. Biological characteristics of cultured cells derived from various types of human brain tumors. Hum. Cell 17 (2004) 117-124
11. Rutka J.T., Giblin B.A., Dougherty B.A., McCulloch J.R., DeArmond S.J., and Rosenblum M.L. An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J. Neuropathol. Exp. Neurol. 45 (1986) 285-303
12. Feurer D.J., and Weller R.O. Barrier functions of the leptomeninges: a study of normal meninges and meningiomas in tissue culture. Neuropathol. Appl. Neurobiol. 17 (1991) 391-405
13. McCaffrey T.A., Consigli S., Du B., Falcone D.J., Sanborn T.A., Spokojny A.M., and Bush Jr. H.L. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J. Clin. Invest. 96 (1995) 2667-2675
14. Sable D.B., and Yen J. Growth factor receptor messenger RNA expression in human fetal brain regions. Obstet. Gynecol. 86 (1995) 240-247
15. Ueda M., Yamashita Y., Takahara M., Terai Y., Kumagai K., Ueki K., Kanda K., Hung Y.C., and Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecol. Endocrinol. 16 (2002) 391-402
16. Carome M.A., Striker L.J., Peten E.P., Moore J., Yang C.W., Stetler-Stevenson W.G., and Striker G.E. Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am. J. Physiol. 264 (1993) F923-F929
17. Lehmann J., Retz M., Harder J., Krams M., Kellner U., Hartmann J., Hohgrawe K., Raffenberg U., Gerber M., Loch T., Weichert-Jacobsen K., and Stockle M. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect. Dis. 2 (2002) 20
18. Kobayashi T., Hattori S., and Shinkai H. Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm. Venereol. 83 (2003) 105-107
19. Salo T., Lyons J.G., Rahemtulla F., Birkedal-Hansen H., and Larjava H. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem. 266 (1991) 11436-11441
20. Dang D., Yang Y., Li X., Atakilit A., Regezi J., Eisele D., Ellis D., and Ramos D.M. Matrix metalloproteinases and TGFbeta1 modulate oral tumor cell matrix. Biochem. Biophys. Res. Commun. 316 (2004) 937-942
21. Eickelberg O., Kohler E., Reichenberger F., Bertschin S., Woodtli T., Erne P., Perruchoud A.P., and Roth M. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am. J. Physiol. 276 (1999) L814-L824
22. Roberts A.B., and Sporn M.B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8 (1993) 1-9
23. Derynck R., Zhang Y., and Feng X.H. Smads: transcriptional activators of TGF-beta responses. Cell 95 (1998) 737-740
24. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
25. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425 (2003) 577-584
26. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
27. Aquilina K., Hobbs C., Tucker A., Whitelaw A., and Thoresen M. Do drugs that block transforming growth factor beta reduce posthaemorrhagic ventricular dilatation in a neonatal rat model?. Acta Paediatr. 97 (2008) 1181-1186